-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ud2u8Ixf2Uv5G/SGYnAFEC0ZHJU0kgAVT0sqKOELfhlYvRmeGkpI+9ZiK66zUNsL is0yu1h/+MPIY2WdvDmJXA== 0000930413-10-001907.txt : 20100413 0000930413-10-001907.hdr.sgml : 20100413 20100413204703 ACCESSION NUMBER: 0000930413-10-001907 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100403 FILED AS OF DATE: 20100413 DATE AS OF CHANGE: 20100413 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: del Campo Ralph CENTRAL INDEX KEY: 0001323683 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 10748268 MAIL ADDRESS: STREET 1: C/O ENZON PHARMACEUTICALS INC. STREET 2: RTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER NAME: FORMER CONFORMED NAME: delcampo ralph DATE OF NAME CHANGE: 20050413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908 541 8671 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206 STREET 2: ATT: GENERAL COUNSEL CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4 1 c61130_ex.xml X0303 4 2010-04-03 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001323683 del Campo Ralph C/O ENZON PHARMACEUTICALS INC. 685 RTE 202/206 BRIDGEWATER NJ 08807 0 1 0 0 Chief Operating Officer Common Stock 2010-04-03 4 M 0 12600 A 163222.136 D Common Stock 2010-04-03 4 F 0 4463 10.48 D 158759.136 D Restricted Stock Units 0 2010-04-03 4 M 0 12600 D 2010-04-03 2010-04-03 Common Stock 12600 16800 D Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock. The Reporting Person's beneficial ownership includes an aggregate of 2,500 shares of Common Stock purchased during the six months ended March 31, 2009 pursuant to the Issuer's 2007 Employee Stock Purchase Plan, which is exempt under Rule 16b-3(c). Reporting Person used the proceeds of the disposition solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4. /s/ Ralph del Campo 2010-04-13 -----END PRIVACY-ENHANCED MESSAGE-----